Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization.
ETH researchers have developed plasmonic particles that are relatively easy to produce and have a wide range of applications, including cancer treatment.
Silica-coated gold nanorods with absorption at precisely 780 nm cause action potentials in nerve cells when exposed to laser light.
A study to investigate how nanoparticles could be used to improve the diagnosis and treatment of cardiovascular disease has received £3 million...
New method allows researchers to directly measure nanoparticle degradation in real time within biological environments.
New gel to promote bone growth on implants used in orthopaedic and dental surgical procedures.
The need to develop biocompatible and biodegradable materials has intensified as the fields of bioengineering and regenerative medicine come of age.
Korean scientists have developed a tumor-targeted, bioreducible nanoparticle system that can deliver cytotoxic anticancer drugs to tumor tissues.
New drug delivery method targets cancer cells – not the entire body – and limits chemotherapy side effects.
New core/shell structure nanoparticles have been reported by a team led by Peking University researchers.